All together, our data support the suggestion that DNAJB3 can potentially play a protective role against obesity, and thus targeting DNAJB3 may have a potential therapeutic benefit for the control and management of obesity and insulin resistance. This evidence concerns the gene DNAJB3 and obesity disorder.